Skip to main content

Robert C. Wolf, PharmD

Assistant Professor, Department of Hematology & Oncology Pharmacy
Mayo Clinic, Rochester, MN
Authored Items
A Pharmacist’s Perspective on CDK4/6 Inhibitors
Robert C. Wolf, PharmD
March 2018, Supplement - Abemaciclib (Verzenio™), a Novel CDK4/6 Inhibitor, in the Treatment of Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer in Perspectives
Last modified: April 9, 2018